Impact of smoking in patients with suspected coronary artery disease in the randomised DISCHARGE trial
Massimo Mancone,Aldo J Vázquez Mézquita,Lucia Ilaria Birtolo,Pal Maurovich-Horvat,Klaus F Kofoed,Theodora Benedek,Patrick Donnelly,Jose Rodriguez-Palomares,Andrejs Erglis,Cyril Štěchovský,Gintare Šakalytė,Nada Čemerlić Ađić,Matthias Gutberlet,Ignacio Diez,Gershan Davis,Elke Zimmermann,Cezary Kępka,Radosav Vidakovic,Marco Francone,Małgorzata Ilnicka-Suckiel,Fabian Plank,Juhanni Knuuti,Rita Faria,Stephen Schröder,Colin Berry,Luca Saba,Balazs Ruzsics,Nina Rieckmann,Christine Kubiak,Kristian Schultz Hansen,Jaqueline Müller-Nordhorn,Bela Merkely,Per E Sigvardsen,Imre Benedek,Clare Orr,Filipa Xavier Valente,Ligita Zvaigzne,Vojtěch Suchánek,Antanas Jankauskas,Filip Ađić,Michael Woinke,Stephen Keane,Ignacio Lecumberri,Erica Thwaite,Mariusz Kruk,Vladimir Jovanovic,Donata Kuśmierz,Gudren Feuchtner,Mikko Pietilä,Vasco Gama Ribeiro,Tanja Drosch,Christian Delles,Vitanio Palmisano,Michael Fisher,Zsófia D Drobni,Charlotte Kragelund,Rosca Aurelian,Stephanie Kelly,Bruno Garcia Del Blanco,Ainhoa Rubio,Melinda Boussoussou,Jens D Hove,Ioana Rodean,Susan Regan,Hug Cuéllar Calabria,Dávid Becker,Linnea Larsen,Roxana Hodas,Adriane E Napp,Robert Haase,Sarah Feger,Mahmoud Mohamed,Konrad Neumann,Henryk Dreger,Matthias Rief,Viktoria Wieske,Pamela S Douglas,Melanie Estrella,Maria Bosserdt,Peter Martus,Lina M Serna-Higuita,Jonathan D Dodd,Marc Dewey
DOI: https://doi.org/10.1007/s00330-023-10355-2
Abstract:Objectives: To investigate if the effect of cardiac computed tomography (CT) vs. invasive coronary angiography (ICA) on cardiovascular events differs based on smoking status. Materials and methods: This pre-specified subgroup analysis of the pragmatic, prospective, multicentre, randomised DISCHARGE trial (NCT02400229) involved 3561 patients with suspected coronary artery disease (CAD). The primary endpoint was major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, or stroke). Secondary endpoints included an expanded MACE composite (MACE, transient ischaemic attack, or major procedure-related complications). Results: Of 3445 randomised patients with smoking data (mean age 59.1 years + / - 9.7, 1151 men), at 3.5-year follow-up, the effect of CT vs. ICA on MACE was consistent across smoking groups (p for interaction = 0.98). The percutaneous coronary intervention rate was significantly lower with a CT-first strategy in smokers and former smokers (p = 0.01 for both). A CT-first strategy reduced the hazard of major procedure-related complications (HR: 0.21, 95% CI: 0.03, 0.81; p = 0.045) across smoking groups. In current smokers, the expanded MACE composite was lower in the CT- compared to the ICA-first strategy (2.3% (8) vs 6.0% (18), HR: 0.38; 95% CI: 0.17, 0.88). The rate of non-obstructive CAD was significantly higher in all three smoking groups in the CT-first strategy. Conclusion: For patients with stable chest pain referred for ICA, the clinical outcomes of CT were consistent across smoking status. The CT-first approach led to a higher detection rate of non-obstructive CAD and fewer major procedure-related complications in smokers. Clinical relevance statement: This pre-specified sub-analysis of the DISCHARGE trial confirms that a CT-first strategy in patients with stable chest pain referred for invasive coronary angiography with an intermediate pre-test probability of coronary artery disease is as effective as and safer than invasive coronary angiography, irrespective of smoking status. Trial registration: ClinicalTrials.gov NCT02400229. Key points: • No randomised studies have assessed smoking status on CT effectiveness in symptomatic patients referred for invasive coronary angiography. • A CT-first strategy results in comparable adverse events, fewer complications, and increased coronary artery disease detection, irrespective of smoking status. • A CT-first strategy is safe and effective for stable chest pain patients with intermediate pre-test probability for CAD, including never smokers.